Delivery Order SPE2DB22D1106-SPE2DB25FFFH2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,916.80 on July 31, 2025, for the supply of Enoxaparin 300 mg/3 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, and performance will be executed from the awardee's facility in Conshohocken, Pennsylvania. Enoxaparin is a low-molecular-weight heparin used for anticoagulation therapy in military and federal healthcare settings. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,342.96 to AmerisourceBergen Drug Corp for the supply of Enoxaparin 100 mg/mL syringes on September 19, 2025. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded through the federal procurement...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Enoxaparin 300 mg/3 ml vials with a ceiling value of $1,372.20. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The contract was awarded on a competitive basis with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,215,870 units of the drug Enoxaparin 40 mg/0.4 ml syringe. The contract has a firm fixed price of $1,204.92 and an ultimate completion date of January 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Enoxaparin 100 mg/ml syringes valued at $2,467.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $115,680 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562099039 enoxaparin sodium injection, 40 mg/0.4 mL prefilled syringes. The order is to provide 0.4 mL syringes of the low molecular weight heparin drug to support Department of Defense medical readiness programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under firm fixed pricing. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $335,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg/ml enoxaparin syringes. As the prime contractor, Amerisourcebergen will deliver the anticoagulant drug to a facility in Conshohocken, Pennsylvania by July 6, 2023 in support of the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA medical product...
- The Defense Logistics Agency awarded a $2,518.74 delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Enoxaparin 40 mg/0.4 mL syringes with an ultimate completion date of September 2, 2025. This competitive award, priced on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency Troop Support Medical awarded a $39,870 delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division. The firm fixed price order is for the delivery of 4561866161 Enoxaparin 60 mg/0.6 ml syringes to a facility in Conshohocken, Pennsylvania. Enoxaparin is an anticoagulant medication frequently used in hospitals. The order runs from August 18-21, 2023 and was awarded under the Medical-Surgical Prime Vendor program, which provides medical supplies to...
- This is a $1,135.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 150 mg/mL enoxaparin syringes, with a period of performance through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFH2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,777.94 to AmerisourceBergen Drug Corp for the supply of Enoxaparin 40 mg/0.4 ml syringes on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Enoxaparin is a low-molecular-weight heparin used for anticoagulation therapy, representing a critical pharmaceutical supply for military and federal healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Health Agency and other federal healthcare systems, supplying an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's substantial IDC with DLA enables flexible fulfillment of critical pharmaceutical needs for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/26/25 |